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Objective: To evaluate glycaemic targets set by diabetes teams, their
perception by adolescents and parents, and their influence on metabolic
control.
Methods: Clinical data and questionnaires were completed by adolescents,
parents/carers and diabetes teams in 21 international centres. HbA1c was
measured centrally.
Results: A total of 2062 adolescents completed questionnaires (age 14.4 ± 2.3
yr; diabetes duration 6.1 ± 3.5 yr). Mean HbA1c = 8.2 ± 1.4% with
significant differences between centres (F = 12.3; p < 0.001) range from 7.4 to
9.1%. There was a significant correlation between parent (r = 0.20) and
adolescent (r = 0.21) reports of their perceived ideal HbA1c and their actual
HbA1c result (p < 0.001), and a stronger association between parents’
(r = 0.39) and adolescents’ (r = 0.4) reports of the HbA1c they would be
happy with and their actual HbA1c result. There were significant differences
between centres on parent and adolescent reports of ideal and happy with
HbA1c (8.1 < F > 17.4; p < 0.001). A lower target HbA1c and greater
consistency between members of teams within centres were associated with
lower centre HbA1c (F = 16.0; df = 15; p < 0.001).
Conclusions: Clear and consistent setting of glycaemic targets by diabetes
teams is strongly associated with HbA1c outcome in adolescents. Target
setting appears to play a significant role in explaining the differences in
metabolic outcomes between centres.
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The Hvidoere Study Group (HSG) on Childhood
Diabetes has investigated metabolic control in
large cohorts of adolescents from more than 20
paediatric diabetes centres worldwide. This research
has demonstrated that there are substantial differences
in the metabolic outcomes between centres, the
differences are relatively stable over time, they emerge
early in the life course of newly diagnosed young
people, are not attributable to differences in population
demographics and are largely unaffected by attempts
to improve outcomes by many of the centres (1–3).
The most recent study confirmed that the differences
are not attributable to specific insulin regimens but
seem to be influenced by a centre’s effectiveness in
implementing treatment regimens (3).
In the HSG Centre Differences Study 2005, a wide
range of psychological, social, cultural and service
delivery factors have been explored which might
account for the centre differences. We have reported
that family dynamics are important predictors of
metabolic outcomes in individual adolescents but
the effects are relatively consistent across centres
and, therefore, do not account for the substantial
inter-centre differences (4). During the development
of this study, discussion among the research group
members suggested that there might be differences
in the aggressiveness with which centres pursued
metabolic control targets. With literature suggesting
that patient goals are strong predictors of outcomes in
chronic diseases (5, 6), it is possible that differences
in targets set by health care professionals (HCPs)
and their perception by patients might influence
metabolic outcomes. In diabetes, there is a dearth of
information on the relationship between professionals’
and individual’s goals, although one study in adults
with type 2 diabetes has shown that centre differences
in metabolic outcomes can be attributable partly to the
differences in fasting blood glucose (FBG) targets set
by physicians and GPs (7).
This paper describes the relationship betweenHCPs’,
parents’ and adolescents’ self-reported targets for
glycaemic control, and the glycaemic outcomes in the
adolescents and centres.
Research design and methods
An observational multicentre, cross-sectional study
was performed between March and October 2005,
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involving 21 paediatric diabetes departments from
19 countries in Europe, Japan, Australia and North
America. Adolescents (aged 11–18 yr; diabetes
duration >12months), parents and HCPs were invited
to participate. Each centre was limited to a maximum
of 200 adolescent participants. If a centre had more
than 200 eligible adolescents, only the patients seen by
the one Hvidoere member were invited.
The case report form (CRF) included information
on age, gender, height, weight, duration of diabetes,
number of severe hypoglycaemic events (defined as
seizures or loss of consciousness in the 3months
preceding blood sampling) and number of episodes
of diabetic ketoacidosis (DKA necessitating hospital
admission in the last year). The number of insulin
injections, types of insulin and injection devices were
recorded. Information was obtained on concomitant
medical conditions (coeliac disease, thyroid disease,
epilepsy, asthma or other). As a marker for
ethnicity/minority group status, the CRF recorded
whether there were language difficulties leading to
communication problems with the diabetes team.
All HCPs within each diabetes team completed a
questionnaire. They were asked ‘What do you consider
as the most realistic and practical targets for HbA1c?’
They were invited to give their responses for three age
groups: 0–5, 6–10 and 11–18 yr, with five response
options available (<7.0; 7.0–7.4; 7.5–7.9; 8.0–9.0% or
no specific target). Only their responses for the 11–18
age group are analyzed here.
The adolescents and parents completed compre-
hensive questionnaires and were asked two specific
questions ‘About your long term sugar test, HbA1c,
what do you think the ideal result should be?’ and
‘What result would you be happy with today?’ The
responses available were the same as for the HCPs,
with the exception that ‘no specific target’ was replaced
with ‘do not know’.
A capillary blood sample was provided by
participants and analyzed at Steno Diabetes Centre,
Gentofte, Denmark. HbA1c was DCCT aligned
(normal range 4.4–6.3%, mean 5.4% and an inter-
assay SD of 0.15% by the Tosoh method). Details of
transportation and stability of specimens have been
published (1). The study was performed according
to the criteria of the Helsinki II Declaration and
was approved by the local Ethics Committee at each
centre.
Statistical analysis
Datawere all double entered at a central administration
centre, and ambiguous data on the CRF were resolved
by direct contact with participating centres. All
analysis was completed using SPSS v15. Two group
comparisons were conducted using simple independent
t-tests, whereLevene’s tests showed non-equal variance
between groups, the appropriate corrected t and
p values are cited. Associations between individual
targets (adolescent and parent) and HbA1c were tested
using analysis of variance, with planned comparisons.
Correlations between ordinal variables were conducted
using Spearman’s ρ correlation coefficient, for mixed
level data using Kendall’s τ and for parametric data
using Pearson’s product moment coefficient (with all
report results being significant at p < 0.001, unless
otherwise stated). In multiple regression analysis to
predict HbA1c, insulin regimens were dummy coded,
with demographic and medical characteristics entered
using stepwise entry.
Results
A total of 2269 eligible individuals attended clinics
during the recruitment period. Of these, 2062 (91%)
adolescents completed a questionnaire and 2036 (90%)
provided a blood sample for assay.
Mean HbA1c = 8.2 ± 1.4% with significant differ-
ences between centres (F = 12.3; p < 0.001) range from
7.4 to 9.1%. Details of the sample demographics have
been reported elsewhere, but the sample providing
blood samples had a shorter duration of diabetes (3).
There were no other significant differences for demo-
graphic or medical characteristics.
A total of 152 HCPs completed the team members’
questionnaire, with no missing responses. Most of
the respondents were paediatric physicians (46%) and
paediatric specialist nurses/educators (32%). Of the
21 centres, 6 did not have a dietitian, 11 had no
psychosocial-orientated health professional, with 3
centres having both a psychologist/psychiatrist and
a social worker as part of the care team. There were no
differences in metabolic outcome between centres with
or without a psychologist, but centres with dietitians
had adolescents with poorer HbA1c (no dietitian n =
573, mean = 8.0%, SD = 1.3; with dietitian n = 1463,
mean = 8.3%, SD = 1.4, t = −4.02, p < 0.001) but
not for other metabolic outcomes (hypoglycaemia or
DKA). There was no relationship between the size of
centres according to the number of adolescents treated
and whether they had a dietitian, but larger diabetes
teams were more likely to have a dietitian (dietitian
mean number in team 8.3, SD = 4.1; no dietitian mean
4.5, SD = 1.6; p < 0.05).
Adolescent and parent targets
Neither parent nor adolescent reported targets were
associated with age, and there were no gender
differences in reported targets. Parent reported targets
were not associated with duration of illness, but
adolescent reported higher ideal target was associated
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with longer duration (F = 2.5; df = 4; p = 0.04) but
not for results they would be happy with. Post hoc
analysis indicated that this was caused by individuals
who reported they did not know what their ideal target
was, had shorter duration of diabetes (mean = 4.3 yr
SD = 3.0) than individuals who reported an answer
(mean = 6.1 yr; SD = 3.5; p < 0.001).
Both adolescent and parent self-reported targets
were associated with the actual adolescent HbA1c,
see Table 1, with planned comparisons indicating a
linear effect in data (in all cases p < 0.001). Thus, as
the reported ideal target or result they would be happy
with today decreased, so did actual HbA1c. However,
these effects were noticeably stronger for results that
adolescents and parents would be happy with today
(F ratio adolescent = 138.6; parent = 131.6) than for
ideal results (F ratio adolescent = 30.1; parent = 27.9).
Furthermore, centre rank was significantly correlated
with adolescent (ideal r = 0.28; happy r = 0.33) and
parent (ideal r = 0.27; happy r = 0.33) reported targets
for HbA1c.
Diabetes team member’s targets
Table 2 provides a graphical summary of the diabetes
team members reported target HbA1c for adolescents,
ranked in order of centre HbA1c. From this table,
it would appear that centres targeting lower HbA1c’s
tend to have adolescents with better metabolic control
and that centres with greater agreement among
professionals tend to have adolescents with lower
HbA1c levels. This was tested using ANOVA, with
the mean centre target (F = 16.0; df = 15; p < 0.001;
η2 = 0.11), median centre target (F = 145.3; df = 3;
p < 0.001; η2 = 0.06) and the variance in centre target
(F = 14.1; df = 13; p < 0.001;η2 = 0.08) all associated
with actual centreHbA1c, with the effect of centre rank
being of an equivalent effect size (F = 12.4; df = 20;
p < 0.001; η2 = 0.11).
Further analysis indicated that the teams treat-
ment target is correlated with adolescent (mean ideal
r = 0.28; median ideal r = 0.26; mean happy with r =
0.30; median happy with r = 0.31) and parent (mean
ideal r = 0.28; median ideal r = 0.26; mean happy with
r = 0.34;median happywith r = 0.35) reported targets,
with these correlations being comparable to associa-
tionswith centre rankedHbA1c status (see above).Fur-
ther support for the association is evident from the fact
that both the team mean and median target HbA1c is
correlated with actual HbA1c (mean r = 0.20; median
r = 0.21). Thus, in centreswhere professionals reported
lower targetHbA1c, both adolescents and parents were
more likely to report lower target HbA1c.
Centre differences in outcome
Given the relationships among adolescent, parent and
HCP treatment targets and centre ranks, these data
were correlated with individual HbA1c, and multi-
ple regression analysis was undertaken to determine
whether these differences in metabolic targets account
for the differences between centres. On step 1 of the
regression, demographic and medical variables asso-
ciated with metabolic control along with centre rank
were entered (3). On step 2, adolescent and parent
reported targets, along with the team target variables
(mean target, median target, variance in target and
interaction term for variance by mean) were entered,
on a stepwise basis. The results of this regression can be
seen in Table 3. Demographic and medical character-
istics accounted for 6% of variance in HbA1c. Centre
rank, entered on step 2, accounted for a further 11% of
variance on step 2. However, the addition of adolescent
reported targets and the result parents would be happy
with, along with interaction term for mean team target
by variance in target, entered the regression model on
step 3. The addition of these target variables increased
the total variance accounted for by the model to 33%.
However, of note is that on entering the treatment tar-
get variables, the effect of centre rank is further reduced
and only accounts for 3% of the variance in HbA1c in
Table 1. Number of adolescents and parents reporting HbA1c targets and mean HbA1c with standard deviation
Reported targets <7.0 7.0–7.4 7.5–7.9 8.0–9.0 Do not know
Adolescent ideal N 975 713 205 25 47
Mean 7.9 8.4 8.8 8.9 8.1
SD 1.4 1.3 1.3 1.0 1.6
Adolescent happy N 639 691 473 141 13
Mean 7.4 8.1 8.6 9.6 10.5
SD 1.2 1.2 1.2 1.5 2.1
Parent ideal N 1056 627 189 18 31
Mean 7.9 8.3 8.9 8.9 8.4
SD 1.3 1.3 1.3 1.3 2.3
Parent happy N 600 694 466 127 18
Mean 7.5 8.0 8.7 9.6 10.6
SD 1.3 1.1 1.1 1.4 2.0
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Table 2. Percentage of professionals in each centre team reporting HbA1c target range for centre
Centre mean
HbA1c (SD)
Target <7.0
(%) 7.0–7.4 (%) 7.5–7.9 (%) 8.0–9.0 (%)
No specific
target (%)
Number of
team members
completing
Number of
adolescents
completing
7.4 (1.1) 100 8 142
7.6 (1.1) 100 3 124
7.7 (1.1) 20 40.0 40 5 68
7.7 (1.2) 100 5 129
7.8 (1.1) 17 83 6 191
7.9 (1.1) 57 43 7 104
8.0 (1.4) 53 43 6 22 192
8.0 (1.2) 100 2 28
8.1 (1.2) 100 7 84
8.2 (1.2) 60 40 6 78
8.2 (1.1) 40 40 10 10 10 200
8.2 (1.3) 33 44 22 10 100
8.3 (1.2) 20.0 60 20 5 78
8.4 (1.7) 60 20 20 5 119
8.4 (1.3) 80 20 7 92
8.6 (1.6) 20 20 60 7 65
8.8 (1.7) 33 44 22 9 101
8.8 (1.6) 100 6 66
8.8 (1.2) 75 25 9 86
9.0 (1.4) 60 20 20 8 109
9.1 (2.0) 20 60 20 5 113
Table 3. Results of multiple regression to predict HbA1c
Beta t P
Step 1
Age 0.069 3.077 0.002
Gender −0.054 −2.517 0.012
Duration of diabetes 0.123 5.432 0.000
Insulin dose (U/kg/24 h) 0.139 6.414 0.000
Insulin regimen (twice
daily free mix)
0.050 2.247 0.025
Centre rank 0.337 15.251 0.000
Step 2
Age 0.041 2.025 0.043
Gender −0.060 −3.136 0.002
Duration of diabetes 0.066 3.236 0.001
Insulin dose (U/kg/24 h) 0.090 4.627 0.000
Insulin regimen (twice
daily free mix)
0.047 2.362 0.018
Centre rank 0.164 7.596 0.000
Adolescent reported
result ‘happy with’
0.298 11.910 0.000
Parent reported result
‘happy with’
0.244 10.339 0.000
Adolescent reported
‘ideal’ result
−0.060 −2.757 0.006
Team target interaction
term
−0.096 −2.728 0.006
the final model. This indicates that differences in treat-
ment targets reported by adolescents, parents and team
members at least partially accounts for the differences
seen between treatment centres. Furthermore, it is
also of note that the effect of age is noticeably reduced
by the addition of the treatment target variables.
Discussion
This study in a large cohort of adolescents has shown
strong correlations between the self-reported glycaemic
targets by the adolescents and their parents, and also
those set by diabetes HCP teams and actual metabolic
outcome. The team outcome is strengthened if there is
consistency in the targets set between various members
of the team. These findings appear to be the most
influential so far uncovered in the search for factors
that are responsible for the substantial and persistent
differences in metabolic control between centres in the
HSG (1–3).
This raises the question as to how goals expressed by
HCPs apparently have such an impact on adolescent
and parent goals and subsequent control. One possibil-
ity is that teams that set higher HbA1c goals are more
concerned about the increased risks of severe hypo-
glycaemia with intensified therapy (8). Perhaps, they
see a stronger relationship between glycaemic con-
trol and hypoglycaemia, and/or see hypoglycaemia as
more adversive than teams which set lower goals. This
would make them more willing to compromise on gly-
caemic targets. This might be an influential mechanism
acknowledging the fear that hypoglycaemia engenders
in parents (9, 10). However, it would seem unlikely
as in this study we have seen no relationship between
rates of hypoglycaemia and centres or insulin regi-
mens (3), and in a previous study the centres with more
optimal glycaemic control tended also to have lower
hypoglycaemia rates (2).
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Alternatively, teams focused on avoidance of
hyperglycaemia might set lower targets but they would
also need to believe that these are achievable by the
young people, and convey this to families. This belief
may help to instil confidence, thus increasing the time
and effort in pursuing lower targets, both in HCPs
and in the adolescents and their carers, making it more
likely that they are successful in achieving their goals.
However, it should be noted that the regression
analysis highlighted that it was the interaction
terms between target and variability of target that
predicted HbA1c. If the regression is repeated without
this interaction term (median target and variability
independently added), only variation in target across
teams predicts HbA1c. Thus, it may be that teams,
which do not agree on treatment goals, do not
create confident working relationships with families,
and both the adolescents and parents recognize these
inconsistencies between team members.
It is interesting to note that several educational
reviews and guidelines on children and adolescents
make little or no mention of target setting being
of importance (11–13), whereas others mention
targets but without supportive evidence (14–17). In
the American Diabetes Association and Australian
paediatric clinical practice guidelines, there are sections
devoted to glycaemic goals but without references to
provide evidence that setting such goals for individuals
has any relevance or efficacy (16, 18). A study in adults
with type 2 diabetes in Italy found that only 14% of
diabetologists and family practitioners used specific
targets for FBG, and the target levels adopted were
extremely heterogeneous (7). In those patients who
were always seen by the same physician, when the
target FBG was ≤6.1mmol/L, the group HbA1c was
7.0%, whereas when the target FBG was ≥7.8mmol/L
the HbA1c was 7.8%. Were these results produced as a
consequence of seeing the same doctor consistently in
accordance with the motivating physician’s wishes or
did the target setting itself invoke a better outcome?
Is there any evidence, in the paediatric literature,
that targets for HbA1c influence outcomes? Schwartz
and Drotar (6) suggest that there is remarkably little
research on goal setting in childhood chronic illness,
using the available literature to provide a framework
for developing research in this area. Of interest is that
in discussing a potential change in the global standards
and reference range for glycated haemoglobin, an
intriguing experience was reported from a centre
in Sweden (19). The glycated haemoglobin reference
range changed twice in opposite directions. When the
reference range was raised, it resulted in childrens’
average HbA1c unexpectedly drifting downwards
towards the previous range and drifting upwards again
when the reference range was lowered. The author
suggested that when the targets were changed, there
was for a period of time a target memory that pushed
levels towards the previous target.
Clinical experience suggests that excellent glycaemic
control is ‘significantly related to the frequency of clinic
attendance (six to nine times per year)’ when ‘HbA1c is
measured at every visit and the patients know the result
and the target’ (20). However, there is no evidence that
the target setting per se has significant influence.
In diabetes management, goal setting has been
highlighted as being important in guided self-
determination, helping patients to develop life skills
and to improve glycaemic control (21). Determination
is one of the key sequences in the process of change,
which in itself is essential in the lives of most peo-
ple with diabetes (22). Also other research focussing
on patients’ descriptions of autonomy support from
HCPs (23) may well influence these processes leading
from goal setting to guided self-determination and then
to changed behaviour resulting in an improvement in
achievement. Despite this theoretical background, in
the field of diabetes, there has been scant regard for
actually testing the effects of goal setting.
How should our results be interpreted? On both an
individual and centre basis it might be argued that
because an adolescent or a centre has consistently
achieved lower HbA1c levels, they will tend to report
lower figures as their targets. This might even explain
to some degree the consistency of reports from team
members from successful centres and also the parents
and adolescents. What comes first – are the lower
targets in themselves conducive to better achievements
in adolescents or are the consistently better outcomes
in certain centres simply reflected in reports of lower
targets?
If targets and goals are seen as the drivers towards
change and improved achievements, then our results
would appear to be consistent with that hypothesis.
Target setting appears to be an important facet of the
whole successful implementation package of intensive
management by an integrated consistent diabetes
team, based not so much on treatment regimens
themselves but on team attitudes and behaviour
towards better diabetes outcomes. When the HSG
looked at the influence of specific insulin regimens
on centre differences, it was found that although a
twice daily free mixing insulin regimen was associated
with the lowest HbA1c, this was not because of the
regimen itself but the way in which that regimen was
implemented in certain centres (2, 3, 20). Some centres
are better than others at using several of the regimens.
It now appears from this study that the better centres
with lowerHbA1c are alsomore successful at educating
the parents and adolescents not only in understanding
the levels of glycated haemoglobin which are desirable
but also providing an environmentwhich enables those
targets to be achieved.
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If specific glycaemic targeting is important in
diabetes what are the mechanisms which make it
work? There appears to be widespread agreement
that to set unattainable goals may lead to feelings
of failure and learned helplessness or powerlessness in
many individuals (24). Our data seem to contradict
this idea because the targets set in the centres which
achieve the best results would seem to be impossible
to achieve in many of the less successful centres.
We are aware that our data, collected from all
members of each centre team cannot inform us of
why particular teams or team members report such
variable targets. Moreover, the unique influence of
individual members has not been explored. This
would require a far more in-depth investigation of
team dynamics, which was beyond the scope of the
current study. It has been widely recommended and
emphasized that diabetes care is optimized by having a
multidisciplinary team (25–28). We have not found an
associationbetween glycaemic control and thenumbers
of HCP within teams. It is difficult to understand
our finding that the adolescents in centres without
a dietitian have slightly lower HbA1c, although this
may be a reflection that these are smaller teams,
who may be more cohesive and have more agreement
around treatment decisions. There is an abundance
of behavioural science literature mainly from North
America which emphasizes the importance of patient
empowerment, the development of collaborative self-
management, including clarification of goals, and is
heavily critical of the physician-centred medical mode
of education (29, 30). However, in several of the better
centres in this study, it would appear that they are
organized very much on a physician-centred education
process so much so that at least one has minimal input
from nurses in clinic education and another has no
dietitian. Therefore the mechanisms by which certain
teams attain greater success in association with setting
targets of glycaemic control remain open to debate
and evaluation. Perhaps they have a grounding in the
cultural environment in which the clinic resides as
previously suggested in an earlier HSG study (31).
In conclusion, we have found a close association
between the targets for glycaemic control perceived by
adolescents and parents and those set by paediatric
teams. Moreover, if members of the teams are
consistent in their advice on targets, the adolescent
HbA1c correlates with those targets. Target setting
appears to be the most influential factor in explaining
centre differences in metabolic control in our studies.
In themanagement chronic diseases such as diabetes,
clear, consistent messages and targets should be
provided for young people and their carers.
We thank Novo Nordisk A/S Denmark for their continuing
administrative and financial support of the Hvidoere Study
Group.
Conflicts of interest
All members of the HSG receive funding from Novo
Nordisk used only for the research studies and travel
expenses to theHvidoereAnnualMeeting inDenmark.
There are no other potential conflicts of interest.
References
1. Mortensen HB,Hougaard P for the Hvidøre
Study Group on Childhood Diabetes. Comparison
of metabolic control in a cross-sectional study of
2,873 children and adolescents with insulin-dependent
diabetes from 18 countries. Diabetes Care 1997: 20:
714–720.
2. Danne T,Mortensen HB, Hougaard P et al. for
the Hvidøre Study Group on Childhood Diabetes.
Persistent differences among centers over 3 years in
glycemic control and hypoglycemia in a study of 3,805
children and adolescents with type 1 diabetes. From the
Hvidøre Study Group 2001. Diabetes Care 2001: 24:
1342–1347.
3. De Beaufort CE, Skinner TC, Swift PGF et al. for
and on behalf of the Hvidoere Study Group on
Childhood Diabetes. Continuing stability of center
differences in pediatric diabetes care: do advances in
diabetes treatment improve outcome? Diabetes Care
2007: 30: 2245–2250.
4. Cameron FJ, Skinner TC, De Beaufort CE et al.
for the Hvidoere Study Group. Are family factors
universally related tometabolic outcomes in adolescents
with type 1 diabetes? Diabet Med 2008: 25: 463–468.
5. MarteauTM, JohnstonM, Baum JD, BlochS.Goals
of treatment in diabetes: a comparison of doctors and
parents of children with diabetes. J Behav Med 1987:
10: 33–48.
6. Schwartz L,Drotar D. Defining the nature and
impact of goals in children and adolescents with a
chronic health condition: a review of research and a
theoretical framework. J Clin Psychol Med Settings
2006: 13: 393–405.
7. Belfiglio M, De Berardis G, Franciosi M et al. for
the QuED Study Group. The relationship between
physicians’ self-reported target fasting blood glucose
levels and metabolic control in type 2 diabetes. Diabetes
Care 2001: 24: 423–429.
8. Diabetes Control and Complications Research Group.
Effect of intensive diabetes treatment on the develop-
ment and progression of long-term complications in
adolescents with insulin-dependent diabetes mellitus.
J Pediatr 1994: 125: 177–188.
9. Fox LA. Diabetes therapy in children: setting age-
appropriate goals. DrugBenefit Trends 2002: 14: 30–35.
10. Clarke WL,Gonder-Frederick A, Snyder AL, Cox
DJ. Maternal fear of hypoglycemia in their children
with insulin dependent diabetes mellitus. J Pediatr
Endocrinol Metab 1998: 11 (Suppl. 1): 189–194.
11. Hampson SE, Skinner TC, Hart J et al. Effects
of educational and psychosocial interventions for
adolescents with diabetes mellitus: a systematic review.
Health Technol Assess 2001: 5: 1–79.
12. Northam EA, Todd S, Cameron FJ. Interventions to
promote optimal health outcomes in children with Type
Pediatric Diabetes 2010: 11: 271–278 277
Swift et al.
1 diabetes–are they effective? Diabet Med 2006: 23:
113–121.
13. Murphy HR, Rayman G, Skinner TC. Psycho-
educational interventions for children and young
people with Type 1 diabetes. Diabet Med 2006: 23:
935–943.
14. Type 1 diabetes: diagnosis and management of type 1
diabetes in children, young people and adults. National
Institute for Clinical Excellence UK (NICE). 2004
(available from http://www.nice.org.uk/pdf/
CG015NICEguideline.pdf).
15. Mensing C, Boucher J, Cypress M et al. National
standards for diabetes self-management education.
Diabetes Care 2005: 28(Suppl. 1): S72–S79.
16. Silverstein J, Klingensmith G, Copeland K et al.
Care of children and adolescents with type 1 diabetes: a
statement of the American Diabetes Association (ADA
Statement). Diabetes Care 2005: 28: 186–212.
17. Swift PGF. Diabetes education in children and
adolescents. ISPAD Clinical Practice Consensus
Guidelines 2009 Compendium. Pediatr Diab 2009:
10(Suppl. 12): 51–57.
18. Clinical practice guidelines: type 1 diabetes in children
and adolescents. Australian Paediatric Endocrine
Group (2004) (available from http://www.chw.edu.au/
prof/services/endocrinology/apeg/apeg handbook
final.pdf).
19. HanasR. Psychological impact of changing the scale of
HbA1c: results affects metabolic control. Diabetes Care
2002: 25: 2110–2111.
20. Dorchy H. Insulin regimens and insulin adjustments
in diabetic children, adolescents and young adults:
personal experience. Diabet Metab (Paris) 2000: 26:
500–507.
21. Zoffmann V, Lauritzen T. Guided self-determination
improves life skills with type 1 diabetes and A1c in
randomized controlled trial. Patient Educ Couns 2006:
64: 78–86.
22. Prochaska JO, Diclemente CC. Stages and processes
of self-change in smoking. Toward an integrative model
of change. J Consult Clin Psychol 1983: 5: 390–395.
23. Williams GC, Freedman ZR, Deci EL. Supporting
autonomy tomotivate patients with diabetes for glucose
control. Diabetes Care 1998: 21: 1644–1651.
24. Aujoulet I, Luminet O, Deccache A. The perspective
of patients in their experience of powerlessness. Qual
Health Res 2007: 17: 772–785.
25. Laron Z, Galatzer A, Amir S, Gil R, Karp M,
Mimouni M. A multidisciplinary, comprehensive,
ambulatory treatment scheme for diabetes mellitus in
children. Diabetes Care 1979: 2: 342–348.
26. Bloomfield S, Farquhar JW. Is a specialist paediatric
diabetic clinic better? ArchDis Child 1990: 65: 139–140.
27. Zgibor JC, Songer TJ, Kelsey SF et al. The associa-
tion of diabetes specialist care with health care practices
and glycemic control in patients with type 1 diabetes:
a cross-sectional analysis from the Pittsburgh epidemi-
ology of diabetes complications study. Diabetes Care
2000: 23: 472–476.
28. LangeK, SassmannH, Von SchultzW, Kordonouri
O, Danne T. Prerequisites for age-appropriate edu-
cation in Type 1 diabetes: a model programme for
paediatric diabetes education in Germany. Pediatr Dia-
betes 2007: 8 (Suppl. 6): 63–71.
29. Anderson RM, Funnell MM. Patient empowerment:
reflection on the challenge of fostering the adoption of a
new paradigm. Patient Educ Couns 2005: 57: 153–157.
30. Glasgow RE, Hiss RG, Anderson RM et al. Behav-
ioral research related to the establishment of a chronic
disease model for diabetes care. Diabetes Care 2001: 24:
124–130.
31. Greene AC, Tripaldi M, Chiarelli F et al. Hvidøre
Study Group for Childhood Diabetes. Cross-cultural
differences in the management of children and
adolescents with diabetes. HormRes 2002: 57(Suppl. 1):
75–77.
278 Pediatric Diabetes 2010: 11: 271–278
Copyright of Pediatric Diabetes is the property of Wiley-Blackwell and its content may not be copied or
emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.
However, users may print, download, or email articles for individual use.
